Literature DB >> 8490887

Care and treatment of long-term survivors of childhood cancer.

J P Neglia1, M E Nesbit.   

Abstract

With the advances in the therapy of childhood cancers over the past 30 years, many children who are now cured of their cancer are moving into adulthood. These patients have, in many cases, been exposed to multiple therapeutic modalities (chemotherapy, radiation, and/or surgery), and in recent years have experienced more and more intensive therapies. Potential late sequelae can involve almost any organ system, but can be predicted, in part, by the chemotherapy or radiation that individuals may have received. These complications may be categorized by their timing relative to the discontinuation of therapy: early (under 5 years), intermediate (5-20 years), or very late (over 20 years). Four potential late sequelae are reviewed (thyroid, cataracts, renal, and osteoporosis), and recommendations are made for screening of at risk individuals for these long-term complications. The need for long-term follow-up of this unique group of individuals is critical as we attempt to completely define the risks and benefits of our therapeutic efforts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490887     DOI: 10.1002/1097-0142(19930515)71:10+<3386::aid-cncr2820711742>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Kevin C Oeffinger; Ann C Mertens; Melissa M Hudson; James G Gurney; Jacqueline Casillas; Hegang Chen; John Whitton; Mark Yeazel; Yutaka Yasui; Leslie L Robison
Journal:  Ann Fam Med       Date:  2004 Jan-Feb       Impact factor: 5.166

2.  Follow-up care for young adult survivors of cancer: lessons from pediatrics.

Authors:  Christine Eiser; Kate Absolom; Diana Greenfield; John Snowden; Robert Coleman; Barry Hancock; Helena Davies
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

3.  Factors Associated With Noncompliance With Long-term Follow-up Care Among Pediatric Cancer Survivors.

Authors:  Katie A Devine; Adrienne Viola; Peter Capucilli; Olle Jane Z Sahler; Jeffrey R Andolina
Journal:  J Pediatr Hematol Oncol       Date:  2017-04       Impact factor: 1.289

4.  Attendance at a survivorship clinic: impact on knowledge and psychosocial adjustment.

Authors:  Jennifer S Ford; Joanne F Chou; Charles A Sklar
Journal:  J Cancer Surviv       Date:  2013-06-22       Impact factor: 4.442

5.  Quality of life in long-term childhood cancer survivors and the relation of late effects and subjective well-being.

Authors:  Sigrid Pemberger; Reinhold Jagsch; Eva Frey; Rosemarie Felder-Puig; Helmut Gadner; Ilse Kryspin-Exner; Reinhard Topf
Journal:  Support Care Cancer       Date:  2004-11-23       Impact factor: 3.603

6.  Differences in activities of daily living performance between long-term pediatric sarcoma survivors and a matched comparison group on standardized testing.

Authors:  Rebecca Parks; Elizabeth K Rasch; Patrick J Mansky; Frances Oakley
Journal:  Pediatr Blood Cancer       Date:  2009-10       Impact factor: 3.167

Review 7.  Bone-mineral density deficits from childhood cancer and its therapy. A review of at-risk patient cohorts and available imaging methods.

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2004-02-12

8.  Perceived physical appearance and adjustment of children with newly diagnosed cancer: a path analytic model.

Authors:  J W Varni; E R Katz; R Colegrove; M Dolgin
Journal:  J Behav Med       Date:  1995-06

9.  An osteoporotic hip fracture in a 14-year-old girl undergoing chemotherapy and operated for knee osteosarcoma.

Authors:  Carmine Zoccali; Umberto Prencipe; Virginia Ferraresi; Nicola Salducca
Journal:  J Orthop Traumatol       Date:  2009-07-31

Review 10.  Dental anomalies in children submitted to antineoplastic therapy.

Authors:  Camila Merida Carrillo; Fernanda Nahás Pires Corrêa; Nilza Nelly Fontana Lopes; Marcelo Fava; Vicente Odone Filho
Journal:  Clinics (Sao Paulo)       Date:  2014-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.